Claforan - 0039-0019-50 - (cefotaxime sodium)

Alphabetical Index


Drug Information of Claforan

Product NDC: 0039-0019
Proprietary Name: Claforan
Non Proprietary Name: cefotaxime sodium
Active Ingredient(s): 2    g/1 & nbsp;   cefotaxime sodium
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS
Dosage Form(s): INJECTION
Coding System: National Drug Codes(NDC)

Labeler Information of Claforan

Product NDC: 0039-0019
Labeler Name: Sanofi-Aventis U.S. LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA050547
Marketing Category: NDA
Start Marketing Date: 20090622

Package Information of Claforan

Package NDC: 0039-0019-50
Package Description: 50 VIAL in 1 PACKAGE (0039-0019-50) > 1 INJECTION in 1 VIAL

NDC Information of Claforan

NDC Code 0039-0019-50
Proprietary Name Claforan
Package Description 50 VIAL in 1 PACKAGE (0039-0019-50) > 1 INJECTION in 1 VIAL
Product NDC 0039-0019
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name cefotaxime sodium
Dosage Form Name INJECTION
Route Name INTRAMUSCULAR; INTRAVENOUS
Start Marketing Date 20090622
Marketing Category Name NDA
Labeler Name Sanofi-Aventis U.S. LLC
Substance Name CEFOTAXIME SODIUM
Strength Number 2
Strength Unit g/1
Pharmaceutical Classes Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]

Complete Information of Claforan


General Information